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Genetic algorithmAbstract The quantitative structure–activity relationship (QSAR) analyses were carried out for a
series of new side chain modiﬁed 4-amino-7-chloroquinolines to ﬁnd out the structural requirements
of their antimalarial activities against both chloroquine sensitive (HB3) and resistant (Dd2) Plasmo-
dium falciparum strain. The statistically signiﬁcant best 2D QSAR models for Dd2, having correla-
tion coefﬁcient (r2) = 0.9188 and cross validated squared correlation coefﬁcient (q2) = 0.8349 with
external predictive ability (pred_r2) = 0.7258 and for HB3, having r2 = 0.9024, q2 = 0.8089 and
pred_r2 = 0.7463 were developed by multiple linear regression coupled with genetic algorithm
(GA–MLR) and stepwise (SW–MLR) forward algorithm, respectively. The results of the present
study may be useful on the designing of more potent analogues as antimalarial agents.
ª 2010 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Malaria is one of the most widespread diseases in the world.
According to WHO estimates 40% of the world’s population
presently live under malarial threat (WHO, 2000). Around
300 and 500 million cases of malaria occur annually, leading
to 1–3 million deaths. Its control is globally a high priority
task. Although effective antimalarial agents have been known
for a long time, the alarming spread of drug resistant strains of
Plasmodium falciparum, which is the most lethal parasite spe-cies, undergoes the urgency and continuous need for the dis-
covery of new therapeutics. A major initiative in this
direction is to ﬁnd enzyme targets that are critical to the dis-
ease process or essential for the survival of the parasite. Iden-
tiﬁcation and design of novel chemical entities speciﬁcally
affecting these targets could lead to better drugs for the treat-
ment of malaria (Sahu et al., 2008). Among old and new drug
targets of malaria, host heme molecule remains one of the most
attractive target and 7-chloroquinoline compounds are very
selective towards heme bindings (Vippagunta et al., 1999).
So, rather than identifying new molecules for efﬁcacy, modi-
ﬁed 7-chloroquinolines having many advantages and efﬁciency
are now in priority for antimalarial chemotherapy.
The quantitative structure–activity relationship (QSAR)
approach helps to correlate the speciﬁc biological activities
or physical properties of a series of compounds with the mea-
sured or computed molecular properties of the compounds, in
terms of descriptors (Hansch et al., 2001). QSAR methodolo-
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ment of new molecules and drugs. There have been many
QSAR researches related to design of anti-malarial drugs so
far (Bhattacharjee et al., 2004; Dascombe et al., 2005;
Katritzky et al., 2006; Adane and Bharatam, 2008;
Deshpande et al., 2009) but a systematic QSAR study is yet
to be carried out for series of new 4-amino-7-chloroquinolines
carrying a branched or a linear side chain with two or three
amino functions.
The aim of present work is to derive some statistically sig-
niﬁcant QSAR models for side chain modiﬁed 4-amino-7-chlo-
roquinolines for their antimalarial activities and to relate
antimalarial activity to its physicochemical properties. The
results obtained may contribute to further designing novel
antimalarial agents.
2. Experimental
2.1. Data set
A data set of 18 compounds of side chain modiﬁed 4-amino-7-
chloroquinolines for antimalarial activities against chloroquine
sensitive (HB3) and resistant (Dd2) P. falciparum strains was
used for the present 2D QSAR study (Yearick et al., 2008).
There is high structural diversity and a sufﬁcient range of the
biological activity in the selected series of these derivatives
(Table 1). It insists as to select these series of compounds for
our QSAR studies. The biological activity values [IC50 (nM)]
reported in literature were converted to their molar units andTable 1 Structures and antimalarial activities of side chain modiﬁe
N
HN N N
Cl
R
n
NCl
NH
RHN n n
4(a-e), 5(a-e) 6(a-b), 7(a-b)
Compound n R
4a 2 H
4b 3 H
4c 4 H
4d 5 H
4e 6 H
5a 2 Et
5b 3 Et
5c 4 Et
5d 5 Et
5e 6 Et
6a 1 Et
6b 1 i-Pr
7a 2 Et
7b 2 i-Pr
16a – Et
16b – H
17a – Et
17b – Hthen further to negative logarithmic scale (pIC50) and subse-
quently used as the dependent variable for the QSAR analysis.
All 18 compounds were built on workspace of molecular
modeling software VLife MDS 3.5 (Vlife Sciences Technolo-
gies Pvt. Ltd. Pune, India) and then the structure was con-
verted to three-dimensional space for further analysis. All
molecules were batch optimized for the minimization of ener-
gies using Merck molecular force ﬁeld (MMFF) followed by
considering distance-dependent dielectric constant of 1.0, con-
vergence criterion or root-mean-square (RMS) gradient at
0.01 kcal/mol A˚ and the iteration limit to 10,000 (Halgren,
1996). The energy-minimized geometry was used for the calcu-
lation of the various 2D descriptors (Individual, Chi, ChiV,
Path count, ChiChain, ChiVChain, Chainpathcount, Cluster,
Pathcluster, Kapa, Element Count, Estate number, Estate con-
tribution, Semi-impirical, Hydophillic–hydophobic and Polar
surface area). The various alignment-independent (AI) descrip-
tors were also calculated. For calculation of alignment, the
independent descriptor was assigned the utmost three attri-
butes. The ﬁrst attribute was T to characterize the topology
of the molecule. The second attribute was the atom type,
and the third attribute was assigned to atoms taking part in
the double or triple bond. The preprocessing of the indepen-
dent variables (i.e., 2D descriptors) was done by removing
invariable (constant column), which resulted in total 153
descriptors to be used for QSAR analysis. In addition to the
VLife descriptors, 50 descriptors were also calculated using
the Win CAChe version 6.1 modeling software (Fujitsu private
limited, Japan).d 7-chloro-4-aminoquinolines.
NHR
NCl
HN
NRR'
NCl
HN
NRR'
16(a-b) 17(a-b)
R0 IC50 (nM) Dd2 IC50 (nM) HB3
– 129 29.2
– 56.3 27.3
– 170 72.5
– 103 46
– 269 82.8
– 31.2 27.3
– 28.1 21.2
– 84.6 24.1
– 43.4 15.7
– 274 62.9
– 128 187
– 99.8 44.1
– 882 716
– 2550 1314
Et 80 26.3
i-Pr 51.8 27.8
Et 76.1 25.5
i-Pr 75.7 31.3
Table 3 Unicolumn statistics of the training and test sets for
QSAR models.
Data set Average Max. Min. SD Total
Dd2
Training 6.847 7.551 5.594 0.530 95.854
Test 7.208 7.363 7.097 0.123 28.830
HB3
Training 4.172 4.674 2.881 0.558 58.410
Test 4.613 4.804 4.505 0.131 18.452
Max., maximum; min., minimum; SD, standard deviation.
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Zheng and Tropsha, 2000; Golbraikh and Tropsha, 2003;
Coi et al., 2009) was adopted for division of training and test
data set comprising of 14 and 4 molecules, respectively, with
dissimilarity value of 2.3 where the dissimilarity value gives
the sphere exclusion radius. The spherical exclusion method
employs the following algorithm: (i) select a point and include
it in the training set; (ii) build a sphere with radius R with a
center in this point; (iii) include all points within the sphere,
except for the center, in the test set; (iv) discard all points in
the sphere from the initial set; (v) if no points are left, stop,
otherwise go to step (i). The most active compound in the data-
set is selected as the starting point for building a sphere (Lather
and Fernandes, 2009). Four compounds, namely, 4b, 5d, 16a
and 17b were used as test set while the remaining molecules
were used as the training set (Table 2). The unicolumn statis-
tics of the training and test sets is reported in Table 3.
2.2. Feature selection and model development
Feature selection is a key step in QSAR analysis. An integral
aspect of any model-building exercise is the selection of an
appropriate set of features with low complexity and good pre-
dictive accuracy. This process forms the basis of a technique
known as feature selection or variable selection (Guyon
and Elisseeff, 2003). Among several search algorithms, step-
wise (SW) forward–backward variable selection method
(Darlington, 1990), genetic algorithms (GA) (Hasegawa
et al., 1999) and simulated annealing (SA) (Zheng and
Tropsha, 2000) based feature selection procedures are most
popular for building QSAR models and can explain the situa-
tion more effectively.
In the selected equations, the cross-correlation limit was
set at 0.5, the number of variables at 10, and the term selec-
tion criteria at q2. An F value was speciﬁed to evaluate the
signiﬁcance of a variable. The variance cutoff was set at 0,
with autoscaling in which the number of random iterations
was set at 100.Table 2 Descriptors used in QSAR models with values.
Compd XY
polarizability
Radius of
gyration
T_2_C_4 Electron
aﬃnity
T_N_N_4 P
A
4a 25.8 33.04 16 0.75 2 3
4b* 25.07 37.64 17 0.75 3 4
4c 27.72 43.35 17 0.75 2 4
4d 25.9 48.86 17 0.75 2 4
4e 28.97 55.24 17 0.74 2 4
5a 8.267 21.37 16 0.67 2 4
5b 52.26 26.25 17 0.66 3 4
5c 1.612 27.23 17 0.69 2 4
5d* 46.14 35.47 17 0.7 2 4
5e 39.15 41.56 17 0.72 2 5
6a 15.08 22.09 23 0.78 3 4
6b 18.34 22.78 23 0.68 3 5
7a 52.94 28 23 0.76 1 5
7b 63 30.4 23 0.73 1 5
16a* 28.95 19.11 20 0.75 2 3
16b 22.53 19.13 20 0.75 2 4
17a 28.13 19.12 20 0.69 1 3
17b* 19.46 20.72 20 0.67 1 4
* Indicates the compounds considered in the test set.In SW forward–backward variable selection algorithm, the
model is repeatedly altered from the previous one by adding or
removing a predictor variable in accordance with the ‘stepping
criteria’ (in this case F= 4 for inclusion; F= 3.99 for exclu-
sion for the forward–backward selection method). In GA
method, population and number of generations were set as
10 and 1000, respectively and speed of 9999. In SA method,
the maximum and minimum temperature were set as 100 K
and 0.01 K, respectively and the temperature was decreased
by 5 units with 100 iterations at that particular temperature.
Multiple linear regression (MLR) analysis is the standard
method for multivariate data analysis (Darlington, 1990). It
estimates the values of the regression coefﬁcients by applying
least squares curve ﬁtting method. For getting reliable results,
dataset having typically ﬁve times as many data points (mole-
cules) as independent variables (descriptors) is required.
2.3. Model quality and validation
The developed QSAR models are evaluated using the follow-
ing statistical measures: n, (the number of compounds in
regression); k, (number of variables); DF, (degree of freedom);
optimum component, (number of optimum PLS components
in the model); r2, (the squared correlation coefﬁcient); r2se,olarizability
HC
T_C_N_4 T_2_C_3 HOMO
energy
T_N_N_5 Kappa3
9.36 5 24 8.71 0 6.43
1.21 3 24 8.72 0 7.04
3.05 5 24 8.71 1 7.64
4.89 5 24 8.71 0 8.28
6.73 5 24 8.71 0 8.91
3.05 6 24 8.61 0 6.91
4.89 3 24 8.62 0 7.51
6.73 5 24 8.64 1 8.1
8.58 5 24 8.66 0 8.73
0.42 5 24 8.67 0 9.35
8.58 3 27 8.9 0 7.65
5.95 3 27 8.75 0 8.63
2.26 7 27 8.89 2 8.82
9.63 7 27 8.84 2 9.77
9.07 5 25 8.71 0 4.35
2.75 5 25 8.68 0 4.84
9.07 5 25 8.63 1 4.35
2.75 5 25 8.6 1 4.84
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(Fischer’s value) for statistical signiﬁcance; q2, (cross-validated
correlation coefﬁcient); q2_se, (standard error of cross-vali-
dated square correlation co-efﬁcient); pred_r2, (r2 for external
test set); pred_r2se, (standard error of predicted squared
regression); Z score, (Z score calculated by the randomization
test); best_ran_q2, (highest q2 value in the randomization test);
best_ran_r2, (highest r2 value in the randomization test). The
regression coefﬁcient r2 is a relative measure of ﬁt by the
regression equation. It represents the part of the variation in
the observed data that is explained by the regression. However,
a QSAR model is considered to be predictive, if the following
conditions are satisﬁed: r2 > 0.6, q2 > 0.6 and pred_r2 > 0.5
(Golbraikh and Tropsha, 2002). The F-test reﬂects the ratio
of the variance explained by the model and the variance due
to the error in the regression. High values of the F-test indicate
that the model is statistically signiﬁcant. The low standard
error of r2 (r2_se), q2 (q2_se) and pred_r2 (Pred_r2se) shows
absolute quality of ﬁtness of the model.
Internal validation was carried out using ‘leave-one-out’
(q2, LOO) method (Cramer et al., 1988). The cross-validated
coefﬁcient, q2, was calculated using the following equation:
q2 ¼ 1
P ðyi  y^iÞ2
P ðyi  ymeanÞ2
where yi, and y^i are the actual and predicted activity of the ith
molecule in the training set, respectively, and ymean is the aver-
age activity of all molecules in the training set.
However, a high q2 value does not necessarily give a suit-
able representation of the real predictive power of the model
for antimalarial ligands. So, an external validation was also
carried out in the present study. The external predictive power
of the model was assessed by predicting pIC50 value of the nine
test set molecules, which were not included in the QSAR model
development. The predictive ability of the selected model was
also conﬁrmed by pred_r2.
pred r2 ¼ 1
P ðyi  y^iÞ2
P ðyi  ymeanÞ2
where yi, and yˆi are the actual and predicted activity of the ith
molecule in the test set, respectively, and ymean is the average
activity of all molecules in the training set.Table 4 Statistical results of QSAR models for side chain modiﬁed
Sr. No. Statistical parameter 2D QSAR results
HB3 Dd2
SW–MLR (Model 1) SW–M
1 r2 0.9024 0.846
2 q2 0.8089 0.682
3 pred_r2 0.7463 0.753
4 r2_se 0.1988 0.237
5 q2_se 0.2782 0.340
6 pred_r2se 0.2649 0.215
7 Z Score Q2 3.45129 4.138
8 Best rand Q2 0.64418 0.220
9 F test 30.8281 18.341
10 Ntraining 14 143. Results and discussion
The QSAR study of 18 new side chain modiﬁed 7-Chloro-4-
aminoquinoline derivatives for antimalarial activities (Table 1)
through MLR methodology, based on various feature selec-
tion methods viz. SW, GA and SA using VLife MDS 3.5 soft-
ware resulted in the following statistically signiﬁcant models
(Table 4), considering the term selection criterion as r2, q2
and pred_r2. The training and test sets were selected by sphere
exclusion method and the models were validated by both inter-
nal and external validation procedure. To ensure a fair com-
parison, the same training and test sets were used for each
model’s development (Table 2). A Uni-column statistics for
training set and test set was generated to check correctness
of selection criteria for trainings and test set molecules
(Table 3).
The maximum and minimum value in training and set were
compared in a way that:
1. The maximum value of pIC50 of test set should be less than
or equal to maximum value of pIC50 of training set.
2. The minimum value of pIC50 of test set should be higher
than or equal to minimum value of pIC50 of training set.
This observation showed that test set was interpolative and
derived within the minimum–maximum range of training set.
The mean and standard deviation of pIC50 values of sets of
training and test provide insights to relative difference of mean
and point density distribution of two sets. The mean of the test
sets was higher than the training sets that indicates the pres-
ence of relatively more active molecules as compared to the
inactive ones. To ensure a fair comparison, the same training
and test sets were used for each model’s development.
Some statistically signiﬁcant 2D QSAR models were chosen
for discussion (Model 1 for HB3 and Model 2–4 for Dd2
strains).
Model 1 (SW–MLR)
pIC50 ¼ 3:4145 ðHOMO EnergyÞ  0:2772ðT N N 5Þ
 0:0868 ðkappa3Þ þ 34:74437-chloro-4-aminoquinolines.
LR (Model 2) GA–MLR (Model 3) SA–MLR (Model 4)
2 0.9188 0.8634
8 0.8349 0.7177
6 0.7258 0.7577
2 0.1723 0.2235
6 0.2458 0.3214
6 0.2257 0.2138
27 2.84884 2.95782
46 0.66627 0.46807
1 37.7243 21.0637
14 14
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against HB3 with a coefﬁcient of determination (r2) = 0.9024
was considered, as the model showed an internal predictive
power (q2 = 0.8089) of 80% and a predictivity for the external
test set (pred_r2 = 0.7463) of about 74%. This model indicates
the positive contribution of HOMO Energy (48.22%). The
descriptors T_N_N_5 deﬁne the count of number of Nitrogen
atoms separated from any other Nitrogen atom by ﬁve bonds
and make a negative contribution (31.30%) to activity (like
in compounds). The last descriptor kappa3 in model represents
to third kappa shape index. The descriptor is negatively corre-
lated (20.49%) with biological activity in the QSAR models
which suggests that decreasing the kappa3 of the compounds
will lead to increased activity.
The descriptors selected for this model are summarized in
Table 2 and the correlation matrix between the physico-chem-
ical parameters and the biological activity for the models 1 is
presented in Table 5.
Model 2 (SW–MLR)
pIC50 ¼ 0:0087 ðXY PolarizabilityÞ
 0:0273 ðRadius of gyrationÞ  0:0873 ðT 2 C 4Þ
þ 9:3303Model 3 (GA–MLR)
pIC50 ¼ 6:0997 ðElectron AffinityÞ þ 0:3447 ðT N N 4Þ
 0:0577 ðpolarizability AHCÞ þ 13:2661Model 4 (SA–MLR)
pIC50 ¼ 0:0268 ðRadius of gyrationÞ  0:2016 ðT C N 4Þ
 0:2935 ðT 2 C 3Þ þ 16:0153Table 5 Correlation matrix for descriptors inﬂuencing the
antimalarial activity against HB3 (Model 1).
pIC50 HOMO energy T_N_N_5 Kappa3
pIC50 1
HOMO energy 0.825 1
T_N_N_5 0.675 0.347 1
Kappa3 0.52 0.421 0.162 1
Table 6 Correlation matrix indicating inter-correlation between de
pIC50 Electron a
pIC50 1
Electron aﬃnity 0.47524 1
T_N_N_4 0.460288 0.058763
Polarizability AHC 0.66301 0.0105The SW–MLR, GA–MLR and SA–MLR models predict the
training data with an r2 of 0.8462, 0.9188 and 0.8634 together
with root mean square error (RMSE) estimating to 0.2372,
0.1723 and 0.2235, respectively. However, the prediction result
for the test set were 0.7536, 0.7258 and 0.7577 with RMSE val-
ues 0.2156, 0.2257 and 0.2138, indicating that the MLR models
are quite capable of estimating the ﬁt for the dataset of new
side chain modiﬁed 7-Chloro-4-aminoquinolines.
The statistically best signiﬁcant model (Model 3) obtained
by the GA–MLR shows 91.88% variance in the observed
activity values. The low r2_se = 0.1723 demonstrates accuracy
of the model. The F test value, 37.7243 shows the overall sta-
tistical signiﬁcance level to be 99.99% of the model, which
means that the probability of failure for model is 1 in
10,000. Cross validated q2 of this model, 0.8349, indicates good
internal prediction power of the model. Another parameter for
predictivity of test set compounds is high (pred_r2 = 0.7258),
which shows good external predictive power of the model.
In this QSAR Model 3, the positive coefﬁcient (29.27%) of
T_N_N_4 (count of number of Nitrogen atoms separated from
any other Nitrogen atom by four bonds) showed that increase
in the values of this descriptor is beneﬁcial for the antimalarial
activity (Like in compound 5a). The negative coefﬁcient of
Electron Afﬁnity (27.81%) and polarizability AHC
(42.93%) showed that increase in the values of these descrip-
tors is detrimental for the antimalarial activity (Like in com-
pounds 7a, 7b).
The descriptors selected for best QSAR models 3 are sum-
marized in Table 2 and the correlation matrixes between the
physico-chemical parameters and the biological activity for
this model are presented in Table 6.
The QSAR Model 2 shows a negative correlation with
descriptors XY polarizability (34.82%), Radius of gyration
(36.28%) and T_2_C_4 (This is the count of number of dou-
ble bounded atoms separated from Carbon atom by four
bonds) (28.89%). Likewise, the QSAR Model 4 shows a neg-
ative correlation with descriptors Radius of gyration
(13.13%), T_C_N_4 (count of number of Carbon atoms sep-
arated from any Nitrogen atom by four bond distance)
(26.52%) and T_2_C_3 (count of number of double bounded
atoms separated from Carbon atom by three bonds)
(41.35%).
The plots of calculated vs. observed values of pIC50 for best
Models 1 and 3 are shown in Fig. 1. The predicted (LOO)
activities of the compounds by the above best models are
shown in Table 7.
4. Conclusion
The present work shows how a set of antimalarial activities of
various 4-quinolylhydrazones may be treated statistically toscriptors and antimalarial activity against Dd2 (Model 3).
ﬃnity T_N_N_4 Polarizability AHC
1
0.04618 1
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5
5.5
6
6.5
7
7.5
8
5 5.5 6 6.5 7 7.5 8
Observed Activity
Pr
ed
ict
ed
 A
ct
ivi
ty
Training
Test
Predictivity of Model 3
R2 = 0.8824
5
5.5
6
6.5
7
7.5
8
5 5.5 6 6.5 7 7.5 8
Observed Activity
Pr
ed
ic
te
d 
Ac
tiv
ity
Training
Test
Figure 1 Correlation plots of observed and predicted activities of the training and test compounds for best QSAR Models 1 and 3.
Table 7 Comparative observed and predicted activities (LOO) of side chain modiﬁed 7-chloro-4-aminoquinolines by best QSAR
models.
Compound Exp. pIC50 (M) HB3 Model-1 (SW–MLR) Exp. pIC50 (M) Dd2 Model-3 (GA–MLR)
Pred. pIC50
aRes. Pred. pIC50
aRes.
4a 7.535 7.439 0.095 6.889 7.14 0.25
4b 7.564 7.373 0.191 7.249 7.33 0.08
4c 7.14 7.064 0.076 6.77 6.909 0.14
4d 7.337 7.285 0.052 6.987 6.797 0.19
4e 7.082 7.248 0.17 6.57 6.77 0.2
5a 7.564 7.759 0.2 7.506 7.385 0.121
5b 7.674 7.673 0.001 7.551 7.672 0.12
5c 7.618 7.249 0.369 7.073 7.057 0.016
5d 7.804 7.424 0.38 7.363 7.034 0.329
5e 7.201 7.339 0.14 6.562 6.686 0.12
6a 6.728 6.708 0.02 6.893 6.765 0.128
6b 7.356 7.105 0.251 7.001 6.901 0.1
7a 6.145 6.08 0.065 6.055 5.954 0.1
7b 5.881 5.151 0.27 5.593 5.706 0.11
16a 7.58 7.613 0.03 7.097 7.109 0.01
16b 7.556 7.68 0.12 7.119 6.945 0.174
17a 7.593 7.63 0.04 7.286 7.166 0.119
17b 7.504 7.672 0.17 7.121 7.058 0.063
a The difference between experimental and predicted values.
706 N.K. Sahu et al.uncover the molecular characteristics which are essential for
high activity. The generated models were analyzed and vali-
dated for their statistical signiﬁcance and external prediction
power. The awareness and understanding of the descriptors
involved in antimalarial activity of these compounds could
provide a great opportunity for the ligand structures design
with appropriate features, and for the explanation of the
way in which these features affect the biological data upon
binding to the respective receptor target. The results derived
may be useful in further designing more novel antimalarial
agents in series.Acknowledgments
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